Legacy Capital Group California, Inc. Teva Pharmaceutical Industries LTD Transaction History
Legacy Capital Group California, Inc.
- $328 Billion
- Q4 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 10,109 shares of TEVA stock, worth $170,134. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,109Holding current value
$170,134% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
647Shares Held
587MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$723 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$656 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$610 Million35.87% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$485 Million3.32% of portfolio
-
Exor Capital LLP London, X027.2MShares$458 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $18.7B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...